Inhibins and activins: roles in clinical practice
1996; Wiley; Volume: 103; Issue: 10 Linguagem: Inglês
10.1111/j.1471-0528.1996.tb09541.x
ISSN1471-0528
Autores Tópico(s)Urological Disorders and Treatments
ResumoBJOG: An International Journal of Obstetrics & GynaecologyVolume 103, Issue 10 p. 945-956 Inhibins and activins: roles in clinical practice Euan M. Wallace, Euan M. Wallace Lecturer Department of Obstetrics and Gynaecology, University of Edinburgh, Edinburgh, ScotlandSearch for more papers by this authorDavid L. Healy, David L. Healy Professor Department of Obstetrics and Gynaecology, Monash University, Clayton Road, Clayton, Victoria 3168, AustraliaSearch for more papers by this author Euan M. Wallace, Euan M. Wallace Lecturer Department of Obstetrics and Gynaecology, University of Edinburgh, Edinburgh, ScotlandSearch for more papers by this authorDavid L. Healy, David L. Healy Professor Department of Obstetrics and Gynaecology, Monash University, Clayton Road, Clayton, Victoria 3168, AustraliaSearch for more papers by this author First published: October 1996 https://doi.org/10.1111/j.1471-0528.1996.tb09541.xCitations: 43Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 McCullagh DR. Dual endocrine activity of the testis. Science 1932; 76: 19–20. 2 Franchimont P, Millet D, Vendrrely E, Letawe J, Legros JJ, Netter A. Relationship between spermatogenesis and serum gonadotrophin levels in azoospermia and oligospermia. J CIin Endocrinol Metab 1972; 34: 1003–1008. 3 Setchell BP, Jacks F. Inhibin like activity in rete testis fluid. Endocrinology 1974; 62: 675–676. 4 Keogh EJ, Lee VLWK, Rennie GC, Burger HG, Hudson B, de Kretser DM. Selective suppression of FSH by testicular extracts. Endocrinology 1976; 98: 997–1004. 5 de Jong FH, Sharpe RM. Evidence for inhibin-like activity in bovine follicular fluid. Nature 1976; 263: 71–72. 6 Burger HG. The story of inhibin–the Melbourne version. Endocrinology 1992; 131: 1585–1586. 7 Robertson DM, Foulds LM, Leversha, L et al. Isolation of inhibin from bovine follicular fluid. Biochem Biophys Res Commun 1985; 126 220–226. 8 Ling N, Ying S-Y, Ueno N, Esch F, Denoroy L, Guillemin R. Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid. Proc Natl Acad Sci U S A 1985; 82: 1217–1221. 9 Vale W, Rivier J, Vaughan J et al. Purification and characterization of an FSH-releasing protein from porcine ovarian follicular fluid. Nature 1986; 321: 776–779. 10 Meunier HC, Rivier C, Evans RM, Vale W. Gonadal and Extrago-nadal expression of inhibin α, βA and βB subunits in various tissues predicts diverse functions. Proc Nutl Acad Sci U S A 1988; 85: 247–251. 11 Massague J. The transforming growth factor beta family. Ann Rev CellBiol 1990; 6: 597–641. 12 Kingsley DM. The TGF-6 superfamily: new members, new recaptors and new genetic tests of function in different organisms. Genes Dev 1994; 8: 133–146. 13 Burger HG, Igarashi M. Inhibin: definition and nomenclature, including related substances. Endocrinology 1988; 122: 1701–1702. 14 Ying S-Y. Inhibins, activins and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 1988; 9: 267–293. 15 Robertson DM, de Vos FL, Foulds LM et al. Isolation of 31 kDa form of inhibin from bovine follicular fluid. Mol Cell Endocrinol 1986; 44: 271–277. 16 Miyamoto K, Hasegawa Y, Fukuda M, Igarashi M. Demonstration of the molecular weight forms of inhibin in bovine follicular fluid (bFF) by using monoclonal antibodies to bFF 32 K inhibin. Biochem Biophys Res Commun 1986; 136: 1103–1109. 17 Robertson DM, Sullivan J, Cahir N. Inhibin forms in human plasma. J Endocrinol 1995; 144: 261–269. 18 Robertson DM, Klein R, de Vos, Fl et al. The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin. Biochem Biophys Res Commun 1987; 149: 744–749. 19 Ueno N, Ling N, Ying S-Y, Esch F, Shimasaki S, Guillemin R. Isolation and partial characterisation of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 1987; 84: 8282–8286. 20 Shimonaka M, Inouye S, Shimasaki S, Ling N. Follistatin binds to both activin and inhibin through the common 6–subunit. Endocrinology 1991; 128: 3313–3315. 21 Knunmen LA, Woodruff TK, DeGuzman G, Cox ET, Baly DL, Mann E, Garg S, Wong W-L, Cossum P, Mather JP. Identification and characterisation of binding proteins for inhibin and activin in human serum and follicular fluids. Endocrinology 1993; 132: 431–443. 22 Vaughan JM, Vale WW. A2-macroglobulin is a binding protein of inhibin and activin. Endocrinology 1993; 132: 2038–2050. 23 Vale W, Grant G, Boss M, Backwell R, Guillemin R. Culture of enzymatically dispersed pituitary cells: functional validation of a method. Endocrinology 1972; 91: 562–572. 24 Eddie L, Baker HW, Higginson RE, Hudson B . A bioassay for inhibin using pituitary cell cultures. J Endocrinol 1979; 81: 49–60. 25 Scott RS, Burger HG, Quigg H. A simple and rapid in vitro bioassay for inhibin. Endocrinology 1980; 107: 1536–1542. 26 Woodruff TK, Krummen L, Baly D et al. Inhibin and activin measured in human serum. In: HG Burger, JK Findlay, DM Robertson, D Kretser, F Petraglia, editors. Inhibin and Inhibin-related Proteins. Frontiers in Endocrinology. Rome : Ares-Serono, 1994: 55–68. 27 McLachlan RI, Robertson DM, Burger HG, de Kretser DM. The radioimmunoassay of bovine and human follicular fluid and serum inhibin. Mol Cell Endocrinol 1986; 46: 175–185. 28 Schneyer AL, Mason AJ, Burton LE, Zeigner JR, Crowley WF Jr. Immunoreactive inhibin αsubunit in human serum: implications for radioimmunoassay. J Clin Endocrinol Metab 1990; 70: 1208–1212. 29 Burger HG. Clinical utility of inhibin measurements. J Clin Endocrinol Metab 1993; 76: 1391–1396. 30 Groome N, O'Brien M. Preparation and applications of monoclonal antibodies to inhibin and its subunits. In: HG Burger, J Findlay, DM Robertson, D Kretser, F Petraglia, editors. Inhibin and Inhibin-related Proteins. Frontiers in Endocrinology. Rome : Ares-Serono, 1994: 33–44. 31 Poncelet E, Franchimont P. Two-site enzymoimmunoassays of inhibin. In: HG Burger, J Findlay, DM Robertson, D Kretser, F Petraglia. Inhibin and Inhibin-related Proteins. Frontiers in Endocrinology. Rome : Ares-Serono, 1994: 45–54. 32 Knight PG, Muttakrishna S, Groome NP. Development and application of a two-site enzyme immunoassay for the determination of ‘total’ activin-A concentrations in serum and follicular fluid. J Endocrinol 1996; 148: 267–279. 33 Ishida H, Tashiro H, Watanabe M et al. Measurement of inhibin concentrations in men: study of changes after castration and comparison with androgen levels in testicular tissues, spermatic venous blood, and peripheral venous blood. J Clin Endocrinol Metab 1990; 70: 101e1022. 34 Steinberger A, Steinberger E. Secretion of an FSH-inhibiting factor by cultured Sertoli cells. Endocrinology 1976; 99: 918–921. 35 Le, Gac F, de Krester DM. Inhibin production by Sertoli cell cultures. Mol Cell Endocrinol 1982; 28: 487498. 36 Cuevas P, Ying SY, Ling N et al. Immunohistochemical detection of inhibin in the gonad. Biochem Biophys Res Commun 1987; 142: 23–30. 37 Roberts V, Meunier H, Sawchenko PE, Vale W. Differential production and regulation of inhibin subunits in rat testicular cell types. Endocrinology 1989; 125: 2350–2359. 38 Risbridger GP, Clements J, Robertson DM et al. Immuno- and bio-active inhibin and inhibin alphαsubunit expression in rat Leydig cell cultures. Mol Cell Endocrinol 1989; 66: 119–122. 39 Maddocks S, Shqe RM. Assessment of the contribution of Leydig cells to the secretion of mhibin by the rat testis. Mol Cell Endocrinol 1989; 67: 113–118. 40 Krummen LA, Toppari J, Kim WH et al. Regulation of testicular inhibin subunit messenger ribonucleic acid levels in vivo: effects of hypophysectomy and selective follicle-stimulating hormone replacement. Endocrinology 1989; 125: 1630–1637. 41 Feng ZM, Bdin CW, Chen CLC. Characterisation and regulation of testicular inhibin β-subunit mRNA. Mol Endocrinol 1989; 3: 939–948. 42 Bhasin S, Krummen LA, Swerdloff RS et al. Stage dependent expression of inhibin alpha and beta8 subunits during the cycle of the rat seminiferous epithelium. Endocrinology 1989; 124: 987–991. 43 Moore A, Knunmen LA, Mather P. Inhibins, activins, their binding proteins and receptors: interactions underlying paracrine activity in the testis. Mol Cell Endocrinol 1994; 100: 81–86. 44 Grootenhuis AJ, Timmerman MA, Hordijk PL, de Jong FH. Inhibin in immature rat Sertoli cell conditioned medium: a 32 kDa αβ-B dimer. Mol Cell Endocrinol 1990; 70: 109–116. 45 Illingworth PJ, Groome NP, Byrd W et al. Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab 1996; 81: 1321–1325. 46 McLachlan RI, Matsumoto AM, Burger HG, de Kretser DM, Bremner WJ. Follicle-stimulating hormone is required for quantitatively normal inhibin secretion in men. J CIin Endocrinol Metab 1988; 67: 1305–1308. 47 McLachlan RI, Matsumoto AM, Burger HG, de Kretser DM, Bremner WJ. Relative roles of follicle-stimulating hormone and luteinizing hormone in the control of inhibin secretion in normal men. JClin Invest 1988; 82: 880–884. 48 Wallace EM, Gow SM, Wu FCW. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study I: plasma luteinising hormone, follicle stimulating hormone, testosterone, estradiol and inhibin concentrations. J Clin Endocrinol Metab 1993; 77: 290–293. 49 Burger HG, McLachlan RI, Banagh M et al. Serum inhibin concentrations rise throughout normal male and female puberty. J Clin Endocrinol Metab 1988; 67: 689–694. 50 Burger HG, Tiu SC, Bangah ML, de Kretser DM. Human chorionic gonadotrophin raises serum immunoreactive inhibin levels in men with hypogonadotrophic hypogonadism. Reprod Ferfil Dev 1990; 2: 137–144. 51 Yamaguchi M-A, Mizunuma H, Miyamoto K, Hasegawa Y, Ibuki Y, Igarashi M. Immunoreactive inhibin concentrations in adult men: presence of a circadian rhythm. J Clin Endocrinol Metab 1991; 72: 554–559. 52 Scott RS, Burger HG. An inverse relationship exists between seminal plasma inhibin and serum follicle-stimulating hormone in man. J Clin Endocrinol Metab 1981; 52: 796–803. 53 Tenover JS, McLachlan RI, Dahl KD, Burger HG, de Kretser DM, Bremner WJ. Decreased serum inhibin levels in normal elderly men: evidence for a decline in Sertoli cell function with ageing. J Clin Endocrinol Metab 1988; 67: 455459. 54 Wallace EM, Russell L, Parker AC, Wu FCW. Changes in inhibin, gonadotrophin and testosterone secretion before and during chemotherapy-induced testicular damage: a prospective longitudinal study. J Endocrinol 1990; 127 (Suppl): 110. 55 Medhamurthy R, Culler MD, Gay VL, Negro-Vila A, Plant TM. Evidence that inhibin plays a major role in the regulation of follicle-stimulating hormone secretion in the fully adult male rhesus monkey (Macacamulatta). Endocrinology 1991; 129: 389–395. 56 Abeyawardene SA, Plant TM. Institution of combined treatment with testosterone and charcoal-extracted porcine follicular fluid immediately after orchidectomy prevents the postcastration hyper-secretion of follicle-stimulating hormone in the hypothalamus-lesioned rhesus monkey (Macaca mulatta) receiving an invariant intravenous gonadotropin-releasing hormone infusion. Endocrinology 1989; 124: 1310–1318. 57 de Kretser DM, McLachlan RI, Robertson DM, Burger HG. Serum inhibin levels in normal men and men with testicular disorders. J Endocrinol 1989; 120: 517–523. 58 Booth JD, Meniman GR, Clark RV, Loriaux DL, Sherins RJ. Evidence for Leydig cell dysfunction in infertile men with a selective increase in plasma follicle-stimulating hormone. J Clin Endocrinol Metab 1987; 64: 1194–1198. 59 Tsatsoulis A, Shalet SM, Moms ID, de Kretser DM. Immunoactive inhibin as a marker of Sertoli cell function following cytotoxic damage to the human testis. Horm Res 1990; 34: 254–259. 60 Toebosch AMW, Robertson DM, Trapman J et al. Effects of FSH and IGF-I on immature rat Sertoli cells: inhibin α and.-subunit mRNA levels and inhibin secretion. Mol Cell Endocrinol 1988; 55: 101–105. 61 Wallace EM, Reddi K, Wickings EJ, Baird DT, Hillier SG, Wu FCW. Plasma bioactive and immunoactive follicle stimulating hormone (FSH) in normal and infertile men. J Endocrinol 1989; 121(Suppl): 226. 62 Bergh A, Cajander S. Immunohistochemical localization of inhibin-alpha in the testes of normal men and in men with testicular disorders. IntJAndrol 1990; 13: 463–469. 63 Franchimont P, Croze F, Demoulin A, Bologne R, Hustin J. Effect of inhibin on rat testicular desoxyribonucleic acid (DNA) synthesis in vivo and in vitro. Acta Endocrinol 1981; 98: 312–320. 64 Lin T, Calkins JL, Moms PL, Vale W, Bardin CW. Regulation of Leydig cell function in primary culture by inhibin and activin. Endocrinology 1989; 125: 2134–2140. 65 Mather JP, Attie KM, Woodruff TK, Rice GC, Phillips DM. Activin stimulates spermatogonial proliferation in germ-Sertoli cell cocul-tures from immature rat testis. Endocrinology 1990; 127: 3206–3214. 66 Illingworth PI, Reddi K, Smith KB, Baud DT. The source of inhibin secretion during the human menstrual cycle. J Clin Endocrinol Metab 1991; 73: 667–673. 67 Tsonis CG, Messinis IE, Templeton AA, McNeilly AS, Baud DT. Gonadotrophic stimulation of inhibin secretion by the human ovary during the follicular and early luteal phase of the cycle. J Clin Endocrinol Metab 1988; 66: 915–921. 68 Hillier SG, Wickings EJ, Illingworth PJ et al. Control of immunoactive inhibin production by human granulosa cells. Clin Endocrinol 1991; 35: 71–78. 69 Findlay JK. An update on the role of inhibin, activin and follistatin as local regulators of folliculogenesis. BiolReprod 1993; 48: 15–23. 70 Hee JP, MacNaughton J, Banagh M et al. Follicle stimulating hormone induces dose-dependant stimulation of immunoreactive inhibin secretion during the follicular phase of the human menstrual cycle. J Clin Endocrinol Metab 1993; 76: 1340–1343. 71 McLachlan RI, Robertson DM, Healy DL, Burger HG, de Kretser DM. Circulating immunoreactive inhibin levels during the normal human menstrual cycle. J Clin Endocrinol Metab 1987; 65 954–961. 72 Reddi K, Wickings EJ, McNeilly AS, Baird DT, Hillier SG. Circulating bioactive follicle stimulating hormone and immunoreactive inhibin during the normal human menstrual cycle. CIin Endocrinol 1990; 33: 547–557. 73 Groome NP, Illingworth PJ, O'Brien M, F'riddle J, Weaver K, McNeilly AS. Quantification of inhibin pro-actontaining forms in human serum by a new ultrasensitive two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 1995; 80: 2926–2932. 74 Muttukrishna S, Fowler PA, Groome NP, Mitchell GG, Robertson WR, Knight PG. Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophins. Hum Reprod 1994 9: 1634–1642. 75 Groome NP, Illingworth PJ, O'Brien M, Cooke I, Ganeson TS, Baird DT, McNeilly AS. Detecion of dimeric inhibin throughout the men strual cycle by two-site enzyme immunoassay. CIin Endocrinol 1994; 40: 717–723. 76 Groome NP, Illingworth PJ, O'Brien M et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996; 81: 140–1405. 77 Demura R, Suzuki T, Tajima S et al. Human plasma free activin and inhibin levels during the menstrual cycle. J CIin Endocrinol Metab 1993; 76: 1080–1082. 78 Muttukrishna S, George L, Fowler PA, Groome NP, Knight PG. Serum concentrations of ‘total’ activin-A during the human men strual cycle and pregnancy. J Reprod Fertil AbstrSer 1995; 15: 226. 79 Hillier SG, Miro F. Inhibin, activin and follistatin. Potential roles in ovarian physiology. Ann N YAcadSci 1993; 687: 29–38. 80 Woodruff TK, Lyon RJ, Hansen SE, Kce GC, Mather JP. Inhibin and activin locally regulate rat ovarian foliculogenesis. Endocrinology 1990; 127: 3196–3205. 81 Hsueh AJW. Paracrine mechanisms involved in granulosa cell differentiation. Clin Endocrinol Metab 1986; 15: 117–134. 82 Xiao S, Robertson DM, Findlay JK. Effects of activin and follicle-stimulating hormone (FSH)-suppressing proteidfollistatin on FSH receptors and hfferentiation of cultured rat granulosa cells. Endocrinology 1992; 131: 1009–1016. 83 Ying S-Y, Becker A, Ling N, Ueno N, Guillemin LR. Inhibin and.β-type transforming growth factor (TGF-p) have opposite modulating effects on the follicle-stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells. Biochem Siophys Res Commun 1986; 136: 96S975. 84 Miro F, Smyth CD, Hillier SG. Development-related effects of recombinant activin on steroid synthesis in rat granulosa cells. Endocrinology 1991; 129: 3388–3394. 85 Xiao S, Findlay JK. Interactions between activin and follicle-stimulating hormone-suppressing protein and their mechanisms of action on cultured rat granulosa cells. Mol Cell Endocrinol 1991; 79: 99–107. 86 LaPolt PS, Soto D, Su J-G et al. Activin stimulation of inhibin secretion and messenger RNA levels in cultured granulosa cells. Mol Endocrinol 1989; 3: 1666–1673. 87 Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH, Mason AJ. Effect of recombinant activin on androgen synthesis in cultured human thecal cells. J CIin Endocrinol Metab 1991; 72: 1206–1211. 88 Hillier SG. Regulatory functions for inhibin and activin in human ovaries. J Endocrinol 1991; 131: 171–175. 89 Baird DT, Smith KB. Inhibin and related peptides in the regulation of reproduction. Oxford Rev Reprod Biol 1993; 15: 191–232. 90 Illingworth PJ, Groome NP, Duncan WC et al. Measurement of circulating inhibin forms during the establishment of pregnancy. J CIin Endocrinol Metab 1996; 81: 1471–1475. 91 McLachlan RI, Healy DL, Lutjen PJ, Findlay JK, de Kretser DM, Burger HG. The maternal ovary is not the source of circulating inhibin levels during human pregnancy. Clin Endocrinol 1987; 27: 663468. 92 Lenton EA, de Kretser DM, Woodward AJ, Robertson DM. Inhibin concentrations throughout the menstrual cycles of normal, infertile and older women compared with those during spontaneous concepttion cycles. J Clin Endocrinol Metub 1991; 73: 1180–1190. 93 Santoro N, Schneyer AL, Ibrahim J, Schmidt CL. Gonadotrophin and inhibin concentrations in early pregnancy in women with and without corpora lutea. Obstet Gynecol 1992; 79: 579–585. 94 Petraglia F, Calza L, Garuti GC et al. Presence and synthesis of inhibin subunits in human decidua. J Clin Endocrinol Metub 1990; 71: 487492. 95 Petraglia F, Aneschi MM, Calza L et al. Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. J Clin Endocrinol Metab 1993; 17: 542–548. 96 JafTe RB, Spencer SJ, Rabinovici J. Activins and inhibins: gonadal peptides during prenatal development and adult life. Ann N YAcud Sci 1993; 687: 1–9. 97 Roberts VJ, Barth SL. Expression of messenger ribonucleic acids encoding the inhibidactivin system during mid- and late-gestation rat embryogenesis. Endocrinology 1994; 134: 914–923. 98 Qu J, Thomas K. Inhibin and activin production in human placenta. EndocrRev 1995; 16 485–507. 99 Healy DL, McLachlan RI, Robertson DM, de Kretser DM, Burger HG. Inhibin: circulating levels in women during ovulation induction and detection in human placenta by specific radioimmunoassay. Ann NY Acad Sci 1988; 541: 162–178. 100 Petraglia F, Sawchenko P, Lim ATW, Rivier LJ, Vale W. Localisation, secretion and action of inhibin in human placenta. Science 1987; 237: 187–189. 101 Petraglia F, Garutti GC, Calza L et al. Inhibin subunits in human placenta: localisation and messenger ribonucleic acid levels during pregnancy. Am J obstet Gynecol 1991; 165: 750–758. 102 Minami S, Yamoto M, Nakano R. Inmunohistochemical localisation of inhibin / activin subunits in human placenta. Obsfet Gynecol 1992; 80: 410414. 103 Rabinovici J, Goldsmith PC, Librach CL, Jaffe RB. Localisation and regulation of the activin-A dirner in human placental cells. J Clin Endocrinol Metab 1992; 75: 571–576. 104 Mersol-Barg MS, Miller KF, Choi CM, Lee AC, Kim MH. Inhibin supresses human chorionic gonadotrophin secretion in term, but not first trimester, placenta. J Clin Endocrinol Metab 1990; 71: 1294–1298. 105 Steele GL, Currie WD, Yuen BH, Jia XG, Perlas E, Leung PCK. Acute stimulation of human chorionic gonadotrophin by recombinant human activin-A in first trimester human trophoblast. Endocrinology 1993; 133: 297–303. 106 Qu J, Thomas K. Changes in bioactive and immunoactive inhibin levels around human labor. J Clin Endocrinol Metab 1992; 74: 1290–1295. 107 Abe Y, Hasegawa Y, Miyamoto K et al. High concentrations of plasma immunoreactive inhibin during normal pregnancy in women. J Clin Endocrinol Metab 1990; 71: 133–137. 108 Tovanabutra S, Illingworth PJ, Ledger WL, Glasier AF, Baud DT. The relationship between peripheral immunoactive inhibin, human chorionic gonadotrophin, oestradiol and progesterone during human pregnancy. Clin Endocrinol 1993; 38: 101–107. 109 Kettel LM, Roseff SJ, Bangah ML, Burger HG, Yen SSC. Circulating levels of inhibin in pregnant women at term: simultaneous disappearance with estradiol and progesterone after delivery. Clin Endocrinol 1991; 34: 19–23. 110 Tabei T, Ochiai K, Terashima Y, Takanashi N. Serum levels of inhibin in maternal and umbilical blood during pregnancy. Am J Obstet Gynecol 1991; 164: 896–900. 111 Qu JP, Vankreken L, Brulet C, Thomas K. Circulating bioactive inhibin levels during human pregnancy. J Clin Endocrinol Metab 1991; 72: 862–866. 112 Muttukrishna S, George L, Fowler PA, Groome NP, Knight PG. Measurement of serum concentrations of inhibin-A (αpA dimer) during human pregnancy. CIin Endocrinol 1995; 2: 391–397. 113 Studd, JWW, Blainey, JD, Bailey, DE. A study of serum proteinchanges in late pregnancy and identification of the pregnancy zone protein using antigen antibody crossed irnmunoelectrophoresis. J Obstet GynaecolBr Comnwlth 1970; 71: 42–51. 114 de Kretser DM, Foulds LM, Hancock M, Robertsonm, DM. Partial characterisation of inhibin, activin and follisiatin in the term human placenta. J Clin Endocrinol Metub 1994; 79: 502–507. 115 Petraglia F, De Vita D, Gallinelli A, Aguzzoli L, Genazzani AR, Romero R, Woodruff TK. Abnormal concentration of maternal serum activin-A in gestational diseases. J Clin Endocrinol Metab 1995; 80: 558–561. 116 Petraglia F, Gallinelli A, De Vita D, Lewis K, Mathers L, Vale W. Activin at parturition: changes in maternal serum levels and evidence for binding sites in placenta and fetal membranes. Obstet Gynecol 1994; 84: 278–282. 117 Petraglia F, Florio P, Gallinelli A et al. Secretion and putative role for activin and CRF in human parturition. Ann N YAcad Sci 1994; 734: 380–386. 118 Yohkaichiya T, Polson DW, Hughes EG et al. Serum immunoactive inhibin levels in early pregnancy after in vitro fertilization and embryo transfer. FertilSteril 1993; 59: 1081–1089. 119 Khalil A, Kaufmann RC, Wortsman J, Winters SJ, Huffman DG. Inhibin in normal and abnormal pregnancy: maternal serum concen tration and partial characterization. Am J Obstet Gynecol 1995; 172: 1019–1025. 120 Gonen R, Perez R, David M, Merksarner R, Sharf M. The association between unexplained second trimester maternal serum hCG elevation and pregnancy complications. Obsfef Gynecol 1992; 80: 83–86. 121 Tuuri T, Eramaa M, Hilden K, Ritvos O. The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 1994; 781 1521–1524. 122 Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 1992; 360: 313–319. 123 Vassalli A, Matzuk MM, Gardner HA, Lee KF, Jaenisch R. Actividinhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev 1994; 8: 414–427. 124 Sawchenko PE, Plotsky PM, Pfeiffer SW et al. Inhibin.β in central neural pathways involved in the control of oxytocin secretion. Nature 1988; 334: 615–617. 125 Plotsky PM, Sawchenko PE, Vale W. Evidence for inhibin β-chain like-peptide mediation of suckling-iiduced oxytocin secretion. 18th Proceedings of the Society for Neuroscience; 1988 Nov 13–18; Toronto , Canada : 627 [abstract no. 256.11]. 126 Burger HG. Diagnostic role of follicle-stimulating hormone measurements during the menopausal transitiow–an analysis of FSH, oestradiol and inhibin. Eur J Endocrinol 1994; 130: 38–72. 127 Lappöhn RE, Burger HG, Bouma J, Bangah M, Krans M, de Bruijn HWA. Inhibin as a marker for granulose-cell tumours. N Engl J Med 1989; 321: 790–793. 128 Healy DL, Burger HG, Marners P et al. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumours. N Engl J Med 1993; 329: 1539–1542. 129 Gurusinghe CJ, Healy DL, Jobling T, Mamers P, Burger HG. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol Oncol 1995; 57: 27–32. 130 Cooke I, O'Brien M, Chamock FM, Groome NP, Ganesan TS. Inhibin as a marker for ovarian cancer. Br J Cancer 1995; 71: 1046–1050. 131 Burger HG, Robertson DM, Cahir N et al. Characterization of inhibin irnmunoreactivity in post-menopausal women with ovarian tumours. Clin Endocrinol 1996; 44: 413–418. 132 Yohkaichiya T, Fukaya T, Hoshiai H, Yajima A, de Kretser DM. Inhibin: a new circulating marker of hydatidiform mole BMJ 1989; 298: 1684–1686. 133 Minami S, Yamoto M, Nakano R. Inmunohistochemical localization of inhibin–activin subunits in hydatidiform mole and invasive mole. Obstet Gynecol 1993; 82: 414–418. 134 Badonnel, Y, Barbe, Legagneur H, Poncelet E, Schweitzer M. Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free β-subunit. Clin Endocrinol 1994; 41: 155–162. 135 Van Lith JMM, Pratt JJ, Beekhuis JR, Mantingh A. Second trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome. PrenatDiugn 1992; 12: 801–806. 136 Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotrophin levels in pregnancies with fetal chromosome abnormalities. PrenatDiugn 1987; 7: 623–630. 137 Macri JN, Kasturi RV, Krantz DA et al. Maternal serum Down syndrome screening: free. protein is a more effective marker than human chorionic gonadotrophin. Am J Obstet Gynecol 1990; 163: 1248–1253. 138 Aitken DA, McCaw G, Crossley JA, Berry E, Connor JM, Spencer K, Macri JN. First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects. Prenut Diagn 1993; 13: 681–689. 139 Spencer K, Wood PJ, Anthony FW. Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome. Ann Clin Biochem 1993; 30: 219–220. 140 Cuckle HS, Holding S, Jones R. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies. Prenut Diugn 1994; 14: 387–390. 141 Wallace EM, Harkness LM, Burns S, Liston WA. Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome. Clin Endocrinol 1994; 41: 483–486. 142 Van Lith JMM, Mantingh A, Pratt JJ. First trimester maternal serum immunoreactive inhibin in chromosomally normal and abnormal pregnancies. Obstet Gynecol 1994; 83: 661–664. 143 Brock DJH, Barron L, Holloway S, Liston WA, Hillier SG, Sepalla M. First-trimester maternal serum biochemical indicators in Down syndrome. Prenat Diugn 1990; 10: 245–251. 144 Groome NP, O'Brien M. Two-site immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach. J Immunol Meth 1993; 165: 167–176. 145 Wallace EM, Grant VE, Swanston IA, Groome NP. Evaluation of maternal serum dimeric inhibin-A as a first trimester marker of Down's syndrome. Prenut Diagn 1995; 15: 359–362. 146 Wallace EM, Swanston IA, McNeilly AS et al. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin-A. Clin Endocrinol 1996; 44: 17–21. 147 Cuckle HS, Holding S, Jones R, Wallace EM, Groome NP. Maternal serum dimeric inhibin A in second trimester Down's syndrome pregnancies. Prenat Diagn 1995; 15: 385–386. 148 Aitken DA, Wallace EM, Crossley JA et al. Dimeric inhibin-A as a marker for Down's syndrome in early pregnancy. N Engl J Med 1996; 334: 1321–1326. 149 Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 1996; 16: 143–153. 150 Wald NJ, George L, Smith D, Densem JW, Petterson K. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 1996; 103: 407–412. 151 Noble PL, Wallace EM, Snijders RJM, Groome NP, Nicolaides KH. Maternal serum inhibin-A and free fi-hCG concentrations in trisomy 21 pregnancies at 10–14 weeks of gestation. Br J Obstet Gynaecol 1996. In press. Citing Literature Volume103, Issue10October 1996Pages 945-956 ReferencesRelatedInformation
Referência(s)